Home
Search:
1146 feeds
357 categories
0 articles (<24 hours)
33 registered users

Use the Mobile version
Mobile

Follow our Twitter feed

View our Linkpartners
Links

Username:
Password:

Register | Retrieve

General


RSS FeedsVertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited Treatment for Sickle Cell Disease and
(WorldNews Switzerland)

 
 

12 december 2017 15:14:17

 
Vertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited Treatment for Sickle Cell Disease and
(WorldNews Switzerland)
 


-Vertex selects CTX001 as first gene edited treatment to be developed as part of collaboration with CRISPR Therapeutics- -Clinical Trial Application for CTX001 submitted in Europe to support initiation of Phase 1/2 clinical study in


 
10 viewsCategory: General > Europe > Switzerland
 
INEOS Forties Pipeline System Media Update
(WorldNews Switzerland)
GMP DNA Sequencing Service at Our Glasgow, UK, Laboratory
(WorldNews Switzerland)
 
 
blog comments powered by Disqus


Copyright © 2008 - 2024 Indigonet Services B.V.. Contact: Tim Hulsen. Read here our privacy notice.
Other websites of Indigonet Services B.V.: Nieuws Vacatures Science Tweets Nachrichten